VTT Technical Research Centre of Finland has developed a mobile app and thumb-size device that help to prevent cerebral infarctions at an early stage, during asymptomatic atrial fibrillation. The mobile device, which detects arrhythmia (irregular heartbeat) has been tested with excellent re ... more
VTT and GE Healthcare developing novel biomarkers to predict Alzheimer’s disease
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer’s disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
Early detection of prodromal AD is vital both for assessing the efficacy of potential AD therapeutic agents as well as new disease modifying therapies are most likely to be effective when initiated during the early stages of disease. The elucidation of early metabolic pathways associated with progression to Alzheimer’s disease may also help in identifying new therapeutic avenues.
In 2010 GE Healthcare entered into “biosignatures initiative” alliance with Janssen Pharmaceutica N.V. (Janssen) to develop diagnostic biosignatures for pre-symptomatic identification of AD. As part of this programme, VTT will apply serum metabolite profiling to validate their recently discovered biochemical signature, as well as to discover novel biomarker candidates predictive of progression to AD.
VTT’s research professor Matej Orešič said: “We are excited about the prospect of collaborating with GE Healthcare to accelerate its research programs and to further develop our biomarker towards a clinical assay applicable in healthcare setting. VTT has over the past years built unique metabolomics and systems biology platforms and acquired vast amount of knowledge on metabolic profiles and pathways in human health and disease, which allow us to identify disease-specific biochemical signatures and pathways. We believe that integration of metabolomics into the GE’s and Janssen’s biosignatures initiative will lead to better tools for early detection of AD and may also lead to better therapeutic options.”
- GE Healthcare
- VTT Technical Resea…
- Alzheimer's disease
Some breweries have taken to resurrecting the flavors of ages past. Adventurous beer makers are extrapolating recipes from clues that archeologists have uncovered from old and even ancient brews found at historical sites. Now scientists have analyzed some of the oldest preserved beer sample ... more
VTT Technical Research Centre of Finland has developed an innovative magnetometer that can replace conventional technology in applications such as neuroimaging, mineral exploration and molecular diagnostics. Its manufacturing costs are between 70 and 80 per cent lower than those of traditio ... more
GE Healthcare, a unit of General Electric Company, announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold ... more
Tecan and GE Healthcare are working together to bring increased quality and efficiency to process development. The collaboration between the two suppliers focuses on high throughput screening of protein purification conditions, using the combination of Tecan’s Freedom EVO® automated worksta ... more
GE Healthcare, a unit of General Electric Company announced that it has completed the acquisition of Whatman plc, a global supplier of filtration products and technologies. The acquisition expands GE Healthcare's offering for life science research and biopharmaceutical manufacturing. GE H ... more
ÄKTA pure chromatography system allows for easy customization thanks to the design of hardware and software. Choose from more than 20 hardware options more
GE expands the range of new generation SEC columns for small-scale preparative purification and analysis. Discover new Superdex™ 75 Increase more
ÄKTA™ lab-scale protein purification systems are designed for purification of biomolecules, providing speed, performance, and flexibility in research and process development. ÄKTA systems use intelligent UNICORN™ system control software to combine simplicity with power in protein purificati ... more
The new generation size exclusion chromatography columns called “Increase” from GE Healthcare offer improved performance than their predecessors. Comprising smaller, more rigid beads with a narrower particle size distribution and a higher selectivity than their predecessors, they offer: R ... more
Protein A-based chromatography is the primary method used to purify monoclonal antibodies (MAbs). Despite much discussion about the high purchase costs, protein A medium (resin) still is a cost-efficient alternative to most other purification techniques. Over the past decade, there has b ... moreWebinarOn-Demand
Significant improvements in a chromatography workflow can be achieved with small changes and proactive choices. Before starting protein purification, it is important to define your requirements and objectives. These may include outlining the required purity, activity and the quantity of th ... moreWebinarOn-Demand
A conversation with Biogen Idec and GE Healthcare Life Sciences. The increasing pressures from global competition plus the need to reduce manufacturing costs are driving the biopharmaceutical industry to improve operational excellence in development and manufacturing. Continuous downstream ... more
- 1Diamond detectors for CERN
- 2Groundbreaking experimental method will speed up protein analysis substantially
- 3We are much more unique than assumed
- 4PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion
- 5Shimadzu acquires specialist for isotope labeled standards
- 6New three-in-one blood test opens door to precision medicine for prostate cancer
- 7LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
- 8State-of-the-art text mining technologies for chemistry
- 9Eurofins expands its footprint in the Balkan region
- 10Waters Corporation elects Flemming Ornskov to Board of Directors
- MRC Technology and Biocartis initiate development of liquid biopsy test for ...
- DKSH extends partnership with LAUDA to Singapore and Taiwan
- Prestigious grant for imaging single molecules
- QIAGEN joins CANCER-ID consortium for liquid biopsy workflows
- University of Illinois announces new partnership with ZEISS labs@location pr ...
- Low-cost material for lighting and diagnostics produces white light imitating sunlight
- A mobile device developed by VTT detects irregular heartbeats
- Brainshake closes €3.5M to advance regulatory approval of blood analysis service
- REACH is the dominant driver for substitution - more action is needed
- Clearing the way for real-world applications of superhydrophobic surfaces